|
|
||||||||
Eur J Cardiothorac Surg 2004;25:43-50
© 2004 Elsevier Science NL
a Minnesota Cardiovascular and Thoracic Surgeons, LLC, 2356 University Avenue West, #258, St. Paul, MN 55114, USA
b University Hospital, Clinic for Thoracic and Cardiovascular Surgery, CH-3010 Bern, Switzerland
c Ohio State University Medical Center, Division of Cardiothoracic Surgery, North Doan Hall 8th Floor, 410 West 10th Avenue, Columbus, OH 43210, USA
d Sarver Heart Center, University of Arizona, Life Sciences North, Room 355, 1501 North Campbell Avenue, Tucson, AZ 85724-5037, USA
e HeartStent Corporation, 7145 Boone Avenue North, Minneapolis, MN 55428, USA
Received 5 November 2002; received in revised form 27 May 2003; accepted 30 July 2003.
* Corresponding author. Tel.: +1-651-917-6160; fax: +1-651-917-6166
e-mail: dremery{at}csa-heart.com
Objective: The objective of this study was to assess acute patency of a new myocardial revascularization device that connects the left ventricular cavity to a coronary artery (termed ventriculo-coronary artery bypass, VCAB) thereby providing proximal and distal blood flow from the site of the anastomosis. Methods: A device made of expanded polytetrafluoroethylene and low density polyethylene was implanted from the base of the left ventricle to the mid left anterior descending coronary artery (LAD) in 11 juvenile domestic pigs using a beating heart approach. Flow rates were measured in the distal LAD before and after implant using ultrasonic flow techniques, and patency was assessed at explant at either 2 or 4 weeks post-implantation. Myocardial perfusion using positron emission tomography (PET) was assessed in a separate set of pigs (n=2) revascularized by VCAB 2 weeks post-implant. Results: Net forward flow distal to the implanted device was 73±15% of native LAD flow. PET demonstrated that the target myocardium was perfused at 85% of that seen in the remote, control myocardium. Device patency rate was 80% (4/5) at 2 weeks in one set of pigs and 83% (5/6) at 4 weeks in a second set of pigs. Histologic analysis showed formation of neointima along the extraventricular segment of the device. Conclusions: This study demonstrates the promise of perfusing ischemic myocardium using a VCAB approach with a device that provides blood flow both proximal and distal to the anastomosis. Patency of the transmyocardial device was encouraging at 2 and 4 weeks and warrants further investigation.
Key Words: Blood vessel prosthesis Coronary artery bypass grafting Myocardial revascularization Vascular patency
This article has been cited by other articles:
![]() |
P. Boekstegers, P. Raake, R. Hinkel, T. Pohl, C. Kupatt, A. Knez, F. Christ, S. Eifert, G. Steinbeck, B. Reichart, et al. Hemodynamic and Vascular Effects of Ventricular Sourcing by Stent-Based Ventricle to Coronary Artery Bypass in Patients With Multivessel Disease Undergoing Coronary Artery Bypass Surgery Circulation, August 30, 2005; 112(9_suppl): I-304 - I-310. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |